A 6-month “self-monitoring” lifestyle modification with increased sunlight exposure modestly improves vitamin D status, lipid profile and glycemic status in overweight and obese Saudi adults with varying glycemic levels

Lipids in Health and Disease

Sudhesh Kumar⁴  Mohammad Alharbi¹  Abdullah M Alnaami³  Kaiser Wani³  Yousef Al-Saleh⁵  Naji J Aljohani⁶  Hanan Alfawaz²  Nasser M Al-Daghri³ 

[1] Diabetes Centers and Units Administration, Ministry of Health, Riyadh, Saudi Arabia;Department of Food Science and Nutrition, College of Food Science and Agriculture King Saud University, Riyadh, Saudi Arabia;Biomarkers Research Program, Biochemistry Department, College of Science, King Saud University, Riyadh, Saudi Arabia;Division of Metabolic and Vascular Health, Clinical Sciences Research Institute, University Hospitals Coventry and Warwickshire Trust, Walsgrave, Coventry CV2 2DX, UK;College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11461, Saudi Arabia;Specialized Diabetes and Endocrine Center, King Fahad Medical City, Faculty of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11525, Saudi Arabia

关键词: Obesity;    Pre-diabetes;    Diabetes mellitus;    Self-monitoring;    Vitamin D;   

Others  :  802532
DOI  :  10.1186/1476-511X-13-87

 received in 2014-04-30, accepted in 2014-05-15,  发布年份 2014

【 摘 要 】

Background

The over-all age-adjusted prevalence of diabetes mellitus type 2 (DMT2) in Saudi Arabia is unprecedented at 31%. Aggressive measures should be done to curb down increasing incidence. In this prospective 6-month study we aim to determine whether a self-monitoring, life-style modification program that includes increased sunlight exposure confer improvement in vitamin D status and health benefits among adult Saudi overweight and obese patients with varying glycemic status.

Methods

A total of 150 overweight and obese Saudi adults with varying glycemic status aged 30–60 years were included in this study. They were divided into 3 groups (Non-DMT2, Pre-diabetes and DMT2). Baseline anthropometrics and blood glucose were taken at baseline and after 6 months. Fasting blood sugar, lipid profile, calcium, albumin and phosphate were measured routinely. Serum 25(OH) vitamin D was measured using standard assays. Within the time period they were instructed to reduce total intake of fat, increased fiber intake and increase sun exposure.

Results

In all groups there was a significant improvement in vitamin D levels as well as serum triglycerides, LDL- and total cholesterol. However, a significant increase in serum glucose levels was noted in the non-DMT2 group, and a significant decrease in HDL-cholesterol in both non-DMT2 and pre-diabetes group. In the pre-diabetes group, 53.2% were able to normalize their fasting blood levels after 6 months, with 8.5% reaching the DMT2 stage and 38.3% remaining pre-diabetic. In all groups there was a significant increase in the prevalence of hypertension.

Conclusion

Improving vitamin D status with modest lifestyle modifications over a short-period translates to improvement in lipid profile except HDL-cholesterol among overweight and obese Saudi adults, but not BMI and blood pressure. Findings of the present study merit further investigation as to whether full vitamin D status correction can delay or prevent onset of DMT2.

【 授权许可】

   
2014 Al-Daghri et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Wild S, Rogli G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
• [2]Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G: Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:293-301.
• [3]Cole A, Nathan DM, Savaria-Porter E, Copeland P, Turchin A, Brunt M, Zusman R, Barrett JA, Wexler D, Case E, McMahon GT, Mort E: An algorithm for the care of type 2 diabetes. Crit Pathw Cardiol 2009, 8:156-165.
• [4]Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G, Handelsman Y, Horton ES, Lebovitz H, Levy P, Moghissi ES, Schwartz SS: Statement by an American association of clinical endocrinologists/American college of endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009, 15:540-559.
• [5]Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American diabetes association and the European association for the study of diabetes. Diabetologia 2009, 52:17-30.
• [6]Warsy AS, El-Hazmi MAF: Diabetes mellitus, hypertension and obesity – common multi-factorial disorders in Saudis. East Mediterr Health J 1999, 5:1236-1242.
• [7]Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, Al-Harthi SS, Arafah MR, Khalil MZ, Khan NB, Al-Khadra A, Al-Marzouki K, Nouh MS, Abdullah M, Attas O, Al-Shahid MS, Al-Mobeireek A: Diabetes mellitus in Saudi Arabia. Saudi Med J 2004, 25:1603-1610.
• [8]Yamaoka K, Tango T: Efficacy of lifestyle education to prevent type 2 diabetes. Diabetes Care 2005, 28:2780-2786.
• [9]Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Sabico SL, Chrousos GP: Diabetes Mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med 2011, 9:76. BioMed Central Full Text
• [10]Bener A, Zirie M, Janahi IM, Al-Hamaq AO, Musallam M, Wareham NJ: Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study in Qatar. Diabetes Res Clin Pract 2009, 84(1):99-106.
• [11]Ganguly SS, Al-Shafaee MA, Bhargava K, Duttagupta KK: Prevalence of prehypertension and associated cardiovascular risk profiles among prediabetic Omani adults. BMC Public Health 2008, 8:108. BioMed Central Full Text
• [12]Saadi H, Carruthers SG, Nagelkerke N, Al-Maskari F, Afandi B, Reed R, Lukic M, Nicholis MG, Kazam E, Alqawi K, Al-Kaabi J, Leduc C, Sabri S, El-Sadiq M, Elkhumaidi S, Agarwal M, Benedict S: Prevalence of diabetes mellitus and its complications in a population-based sample in Al-Ain, United Arab Emirates. Diabetes Res Clin Pract 2007, 78:369-377.
• [13]American Association of Diabetes Educators: Primary prevention of type 2 diabetes. Diabetes Educ 2012, 38(1):147-150.
• [14]Prediabetes and the potential to prevent diabetes Lancet 2012, 379:2213. [No authors listed]
• [15]Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP: Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovascular Diabetol 2012, 11:85. BioMed Central Full Text
• [16]Alkharfy KM, Al-Daghri NM, Sabico SB, Al-Othman A, Moharram O, Alokail MS, Al-Saleh Y, Kumar S, Chrousos GP: Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study. Cardiovasc Diabetol 2013, 12:113. BioMed Central Full Text
• [17]Al-Daghri NM, Alkharfy KM, Al-Saleh Y, Al-Attas OS, Alokail MS, Al-Othman A, Moharram O, El-Kholie E, Sabico S, Kumar S, Chrousos GP: Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism 2012, 61:661-666.
• [18]Kosaka K, Noda M, Kuzuya T: Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005, 67:152-162.
• [19]Tuomilehto J, Lindstrom J, Erikkson JG, Valle TT, Hamalainen H, Illane-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, for the Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
• [20]The Diabetes Prevention Program Research Group: 10-year follow-up of diabetes incidence and weight loss I the diabetes prevention program outcomes study. Lancet 2009, 374:1677-1686.
• [21]Davidson MB, Duran P, Lee ML, Friedman TC: High-dose vitamin D supplementation in people with pre-diabetes and hypovitaminosis D. Diabetes Care 2013, 36:260-266.
• [22]Harris SS, Pittas AG, Palermo NJ: A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 2012, 14:789-794.
• [23]The Diabetes Prevention Program Research group: The influence of age on the effects of lifestyle modification and metformin in the prevention of diabetes. J Gerontol A Biol Med Sci 2006, 61:1075-1081.
• [24]Jorde R, Strand Hutchinson M, Kjaergaard M, Sneve M, Grimnes G: Supplementation with high doses of vitamin D to subjects without vitamin D deficiency may have negative effects: pooled data from four intervention trials in tronso. ISRN Endocrinol 2013, 2013:348705.
• [25]Ponda MP, Huang X, Oda MA, Breslow JL, Kaufman HW: Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 2012, 126(3):270-277.
• [26]Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Sabico SL, Chrousos GP: Decreasing prevalence of the full metabolic syndrome but a persistently high prevalence of dyslipidemia among Adult Arabs. PLoS One 2010, 5:e12159.
• [27]Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Charalampidis P, Livadas S, Kollias A, Sabico SL, Chrousos GP: Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances. Eur J Clin Invest 2013, 43:183-189.
• [28]Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, El-Kholie E, Yousef M, Al-Othman A, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP: Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin Endocrinol (Oxf) 2012, 76:346-350.